iCAD, Inc.
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06T (Image Data Processing OR Generation, IN General).
The verdict
According to USPTO PatentsView, icad ranks #40,821 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #40,821
- of 49,997 US assignees by volume
- 22nd percentile
- by Innovation Score (26.8/100)
- 20.3
- avg claims per patent
- -75%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40821 · US Corporation #40,821 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,821/49,997
- PHOTO-FINISH eyeBrain Medical
- CPC-NARROW G06T · 5 areas
- INNOV-THIN 26.8/100
- CLAIMS-DENSE 20.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -75% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: eyeBrain Medical, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How icad’s 26.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around icad
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- iCAD · this assignee 27
iCAD · this assignee
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows icad's Innovation Score is 26.8/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for icad?
Each dot is one of icad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). icad’s own 20.3 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where icad's grants concentrate
iCAD, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under G06T (Image Data Processing OR Generation, IN General). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, icad sits between eyeBrain Medical, Inc. and iMICRODATA Corporation.
Who files at iCAD's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- eyebrain Medical
eyeBrain Medical, Inc.
6 patents
- fischer Rohrtechn…
fischer Rohrtechnik GmbH
6 patents
- hubergroup Deutsc…
hubergroup Deutschland GmbH
6 patents
- ibenzer
iBenzer Inc.
6 patents
- icell Gene Therap…
iCell Gene Therapeutics LLC
6 patents
- idonate
iDonate LLC
6 patents
- imedi Plus
iMEDI Plus Inc.
6 patents
- imicrodata
iMICRODATA Corporation
6 patents
- icad ◀
iCAD, Inc.
6 patents
What this shows iCAD holds 6 patents at rank #44,256, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near iCAD
By rank, the assignees closest to #44,256 in granted patent volume.
- eyeBrain Medical, Inc. #44,252 · 6 patents
- fischer Rohrtechnik GmbH #44,253 · 6 patents
- hubergroup Deutschland GmbH #44,254 · 6 patents
- iBenzer Inc. #44,255 · 6 patents
- iCell Gene Therapeutics LLC #44,257 · 6 patents
- iDonate LLC #44,258 · 6 patents
- iMEDI Plus Inc. #44,259 · 6 patents
- iMICRODATA Corporation #44,260 · 6 patents
Leaders in G06T (Image Data Processing OR Generation)
Other assignees with the most granted patents in iCAD's primary technology class.
- Samsung Electronics Co., Ltd. 4,120 in class
- Canon Kabushiki Kaisha 3,282 in class
- Apple Inc. 2,522 in class
- Sony Group Corporation 2,484 in class
- Intel Corporation 2,439 in class
- Microsoft Technology Licensing, LLC 2,389 in class
- International Business Machines Corporation 2,281 in class
- Google LLC 2,182 in class
icad's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 22nd percentile higher than 22% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 1 | 16.7% |
| 2019 | 2 | 33.3% |
| 2021 | 1 | 16.7% |
| 2025partial year | 1 | 16.7% |
Which technologies does iCAD, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
iCAD, Inc.'s patent record in context - here's where to go next.
- iCAD, Inc.'s lead technology class is G06T (Image Data Processing OR Generation, IN General), 100% of its portfolio - see every assignee active in that class. Explore G06T
- Ranked #40,821 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare iCAD, Inc. against eyeBrain Medical, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.